Background {#Sec1}
==========

Renal function declines with age such that close to 95% of women aged ≥75 years have a mild to moderate reduction of renal function \[[@CR1]\]. Currently, we are experiencing an unprecedented rise in the number of older adults \[[@CR2]\], and consequently, the prevalence of many age-related diseases will increase, including chronic kidney disease (CKD) and osteoporosis \[[@CR3], [@CR4]\]. Studies show that patients with renal dysfunction exhibit reduced bone mineral density (BMD) and increased risk of fracture \[[@CR5]--[@CR9]\]. Renal dysfunction influences bone in various ways, such as increasing parathyroid hormone levels, abnormal calcium and phosphate metabolism, and vitamin D deficiency \[[@CR10], [@CR11]\]. These effects on mineral homeostasis may be associated with increased bone fragility \[[@CR12]\]. However, there are conflicting reports, on whether renal function affects BMD or fracture risk. Elliott et al. \[[@CR13]\] showed no association between renal dysfunction and fracture risk. Fujita et al. \[[@CR14]\] reported that low renal function is not associated with decreased BMD in community-dwelling elderly men.

Osteoporosis is a serious problem affecting a large number of elderly people. Several studies reported a high prevalence of osteoporosis in postmenopausal women \[[@CR11], [@CR15], [@CR16]\]. Due to the increase of proportion of the elderly population, osteoporosis has become a major public health problem around the world \[[@CR17]--[@CR19]\]. It was estimated that the annual number and costs of osteoporotic fractures will reach as high as 5.99 million fractures and \$25.43 billion in 2050, respectively \[[@CR20]\].

Although other studies have investigated the relationship between renal function and BMD, they are mostly in defined kidney disease \[[@CR5], [@CR21]\]. The data about the effect of renal function on BMD and osteoporosis in otherwise healthy Chinese postmenopausal women are scare. Therefore, the aim of the present study was to investigate the relationship of renal function (using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2009 equations to calculate estimated glomerular filtration rate (eGFR)) with BMD and osteoporosis risk in healthy Chinese postmenopausal women.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

The design and operation of this study have been described \[[@CR22]\]. Briefly, a total of 1096 urban postmenopausal Chinese women were recruited at random. Subjects with any pathological disorders (such as diabetes mellitus, hyperthyroidism, oligomenorrhoea, malabsorption, rheumatoid arthritis or hepatic dysfunction) or subjects using medications (such as glucocorticoids, bisphosphonate, oestrogen, thyroid hormones or statins) known to alter bone metabolism were excluded from our study. Of these, 232 subjects had to be excluded. 15 women were excluded due to lacking of time. Fourteen subjects had to be excluded because of impaired renal function (eGFR \< 60 ml/min/1.73m^2^) \[[@CR23]\]. After excluding 59 participants with abnormal laboratory test results, 776 qualifying healthy postmenopausal women were selected. All subjects agreed to participate in the study and gave written informed consent. The study was approved by the ethics committee of the Second Xiangya Hospital of Central South University (Changsha, China) and was in compliance with the Helsinki Declaration.

Clinical measurements {#Sec4}
---------------------

Each participant answered a detailed self-report questionnaire that included name, age, menopausal duration, marital status, educational background, smoking or alcohol intake, physical exercise, list of medications and history of fractures, and underwent a clinical examination. Physical exercise was defined as ≥30 min/day. Weight (kg) and height (cm) were measured and BMI (kg/m^2^) calculated. BMD values were measured by dual-energy X-ray absorptiometry (DXA) fan-beam bone densitometer (Lunar Prodigy Advance, GE Healthcare, Madison, WI, USA) at the total hip, left femoral neck, and lumbar spine (L1--L4). We classified the BMD results as normal BMD: T-score \> − 2.5 standard deviation (SD) at lumbar spine, femoral neck and total hip, or osteoporosis: T-score ≤ − 2.5 SD in at least one skeletal site \[[@CR24], [@CR25]\].

Blood samples were collected after an overnight fast. Serum calcium (SCa) levels were measured by calcium kit according to the manufacturer's instructions (MedicalSystem Biotechnology CO., Ltd., Ningbo, China). Serum creatinine (SCr) levels were measured by enzymatic method (Kanto Chemical, Tokyo, Japan). Blood urea nitrogen (BUN) levels were measured by enzymatic method (Abbott, Chicago, USA). eGFRs were estimated using the CKD-EPI 2009 equations \[[@CR14]\]. Participants were staged into categories of renal function based on their eGFR alone as follows: (1) normal eGFR (≥ 90.0 ml/min/1.73m^2^), (2) mild decreased eGFR (60 ml/min/1.73m^2^ ≤ eGFR\< 90.0 ml/min/1.73m^2^) \[[@CR23]\].

Statistical analysis {#Sec5}
--------------------

Log transformation was used for BUN, SCr, eGFR, TG, and HDL-C levels when their results were not normally distributed. Data are presented as mean ± SD for continuous variables, median (25, 75) for skewed variables, and percentages for categorical variables. We used the one-way ANOVA test to compare continuous characteristics, and the chi-squared test or Fisher exact test to compare percentages among groups. The correlations between renal function and independent variables were examined by Spearman's correlation coefficient. Multivariable logistic analyses were performed to evaluate the association between eGFR and the presence of osteoporosis in different models. Two models were applied as unadjusted model and adjusted model which adjusted for age, menopausal duration, and BMI. All data were analyzed using SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). *P* value less than 0.05 was considered statistically significant.

Results {#Sec6}
=======

The characteristics of the study participants are presented in Table [1](#Tab1){ref-type="table"}. A total of 776 relatively healthy postmenopausal Chinese women participated in the present study. The mean age was 62.1 ± 6.1 years. Osteoporosis in at least one site (lumbar spine, femoral neck or total hip) was found in 37.2% of participants. We compared various indices between subjects with and without osteoporosis. As shown in Table [1](#Tab1){ref-type="table"}, participants with normal BMD were younger and had higher BMI and shorter menopausal duration (*P* \< 0.001). Table 1Characteristics of participants according to BMDVariablesTotal (*n* = 776)Normal (*n* = 487)Osteoporosis (*n* = 289)*P*Age (years)62.1 ± 6.161.0 ± 5.763.9 ± 6.2\< 0.001Menopausal duration (years)12.6 ± 7.111.1 ± 6.714.9 ± 7.3\< 0.001Height (cm)153.8 ± 5.1154.5 ± 5.0152.7 ± 5.2\< 0.001Weight (kg)55.4 ± 7.857.0 ± 7.652.7 ± 7.4\< 0.001BMI (kg/cm^2^)23.4 ± 3.023.9 ± 2.922.6 ± 2.9\< 0.001BUN (mmol/l)5.3 (4.4, 6.2)5.3 (4.4, 6.3)5.2 (4.4, 6.1)0.455SCr (μmol/l)58.3 (49.4, 66.1)58.7 (50.4, 65.4)57.7 (47.2, 67.1)0.316eGFR (ml/min/ 1.73m^2^)^a^94.7 (85.3, 101.5)95.4 (86.6, 101.5)93.5 (82.4, 101.8)0.216L1-L4 BMD (g/cm^2^)0.933 ± 0.1491.004 ± 0.1210.814 ± 0.110\< 0.001Femoral neck BMD (g/cm^2^)0.735 ± 0.1190.794 ± 0.0980.634 ± 0.078\< 0.001Total hip BMD (g/cm^2^)0.814 ± 0.1250.877 ± 0.0980.707 ± 0.087\< 0.001TG (mmol/l)1.4 (1.1, 2.0)1.5 (1.1, 2.0)1.4 (1.1, 2.0)0.342TC (mmol/l)5.3 ± 0.95.3 ± 0.95.3 ± 0.90.442HDL-C (mmol/l)1.5 (1.3, 1.8)1.5 (1.3, 1.7)1.6 (1.4, 1.8)0.044LDL-C (mmol/l)3.1 ± 0.73.1 ± 0.73.1 ± 0.70.444SCa (mmol/l)2.4 ± 0.12.4 ± 0.12.4 ± 0.10.140Cigarette smoking, %13 (1.7%)7 (1.4%)6 (2.1%)0.567Alcohol consumption, %20 (2.6%)16 (3.3%)4 (1.4%)0.106Physical exercise, %639 (82.3%)405 (83.2%)234 (81.0%)0.439Data are expressed as mean ± SD, median (25, 75) or number with percentage (%) in parentheses*BMD* bone mineral density, *BMI* body mass index, *BUN* blood urea nitrogen, *eGFR* estimated glomerular filtration rate, *HDL-C* high-density lipoprotein cholesterol, *LDL-C* low-density lipoprotein cholesterol, *SCa* serum calcium, *SCr* serum creatinine, *TC* total cholesterol, *TG* triglyceride^a^eGFR calculated using the CKD Epidemiology Collaboration 2009 equation

The analysis according to renal function (Table [2](#Tab2){ref-type="table"}) showed that participants with eGFR ≥90 ml/min/1.73m^2^ were younger and had shorter menopausal duration (*P* \< 0.001). BMD values at femoral neck and total hip, but not at lumbar spine, were significantly lower in women with declining renal function (*P* \< 0.01). As renal function decreased, the percentage of participants with osteoporosis increased (*P* \< 0.05). As shown in Table [3](#Tab3){ref-type="table"}, eGFR was negatively and significantly correlated with age and menopausal duration (*P* \< 0.01). The levels correlated with femoral neck BMD and total hip BMD (*r* = 0.086, and *r* = 0.071, *P* \< 0.05, respectively). SCr levels correlated with age (*r* = 0.107, *P* \< 0.01), menopausal duration (*r* = 0.086, *P* \< 0.05), and TC levels (*r* = 0.074, *P* \< 0.05). BUN was positively correlated with age, menopausal duration (*P* \< 0.01), TC, LDL-C, and SCa levels (*P* \< 0.05). eGFR is computed according to age and SCr concentration. BMD could be influenced by age and menopausal duration. Therefore, we performed subgroup analysis stratified by age and menopausal duration. eGFR did not correlate with BMD at all sites after stratification by age or menopausal duration (Additional file [1](#MOESM1){ref-type="media"}: Tables S1 and S2). Table 2Characteristics of participants according to renal function, measured by eGFRVariablesCategory of eGFR^a^ (ml/min/1.73m^2^)*p*-value\< 90 (*n* = 273)≥90 (*n* = 503)Age (years)65.1 ± 6.060.4 ± 5.5\< 0.001Menopausal duration (years)15.4 ± 7.011.0 ± 6.7\< 0.001Height (cm)153.8 ± 4.9153.8 ± 5.30.858Weight (kg)55.3 ± 7.355.5 ± 8.10.914BMI (kg/cm^2^)23.4 ± 2.823.4 ± 3.10.965BUN (mmol/l)5.7 (4.8, 6.6)5.0 (4.2, 5.9)\< 0.001SCr (μmol/l)69.1 (65.0, 73.7)53.3 (44.0, 58.6)\< 0.001eGFR (ml/min/1.73m^2^)80.3 (74.1, 86.2)99.3 (95.3, 104.9)\< 0.001L1-L4 BMD (g/cm^2^)0.924 ± 0.1420.938 ± 0.1520.195Femoral neck BMD (g/cm^2^)0.717 ± 0.1060.744 ± 0.1250.004Total hip BMD (g/cm^2^)0.796 ± 0.1160.823 ± 0.1290.004TG (mmol/l)1.5 (1.1, 2.1)1.4 (1.1, 2.0)0.991TC (mmol/l)5.4 ± 0.95.3 ± 0.90.169HDL-C (mmol/l)1.5 (1.3, 1.7)1.6 (1.3, 1.8)0.350LDL-C (mmol/l)3.2 ± 0.73.1 ± 0.70.287SCa (mmol/l)2.4 ± 0.12.4 ± 0.10.849Cigarette smoking, %8 (2.9%)5 (1.0%)0.074Alcohol consumption, %6 (2.2%)14 (2.8%)0.623Physical exercise, %231 (84.6%)408 (81.1%)0.222Osteoporosis,%115 (42.1%)174 (34.6%)0.038Data are expressed as mean ± SD, median (25, 75) or number with percentage (%) in parentheses*BMD* bone mineral density, *BMI* body mass index; BUN, blood urea nitrogen, *eGFR* estimated glomerular filtration rate, *HDL-C* high-density lipoprotein cholesterol, *LDL-C* low-density lipoprotein cholesterol, *SCa* serum calcium, *SCr* serum creatinine, *TC* total cholesterol, *TG* triglyceride^a^eGFR calculated using the CKD Epidemiology Collaboration 2009 equation Table 3Correlation analysis of renal function indicators and other variablesVariableseGFR^c^BUNSCrAge (years)−0.426^a^0.136^a^0.107^a^Menopausal duration (years)−0.360^a^0.133^a^0.086^b^BMI (kg/cm^2^)−0.0120.0140.010L1-L4 BMD (g/cm^2^)0.0570.0140.022Femoral neck BMD (g/cm^2^)0.086^b^−0.0250.027Total hip BMD (g/cm^2^)0.071^b^−0.0220.016TG (mmol/l)0.018−0.064−0.022TC (mmol/l)−0.0450.084^b^0.074^b^HDL-C (mmol/l)0.0380.061−0.052LDL-C (mmol/l)−0.0050.079^b^0.025SCa (mmol/l)0.0000.075^b^0.028*BMD* bone mineral density, *BMI* body mass index, *BUN* blood urea nitrogen, *eGFR* estimated glomerular filtration rate, *HDL-C* high-density lipoprotein cholesterol, *LDL-C* low-density lipoprotein cholesterol, *SCa* serum calcium, *SCr* serum creatinine, *TC* total cholesterol, *TG* triglyceride^a^ *P* \< 0.01^b^ *P* \< 0.05^c^eGFR calculated using the CKD Epidemiology Collaboration 2009 equation. r, correlation coefficient

Table [4](#Tab4){ref-type="table"} shows the results of binary logistic regression analyses using osteoporosis as the dependent variable and eGFR groups as the independent variables. In the unadjusted model, lower eGFR class was associated with an increased risk of osteoporosis as compared to the higher eGFR class (odds ratio (OR): 1.38, 95% confidential interval (CI): 1.02--1.86, *P* \< 0.05). However, after adjustment for age, menopausal duration, and BMI, the lower eGFR class was not related to an increase risk of osteoporosis as compared to the higher eGFR class (OR: 0.94, 95%CI: 0.67--1.33, *P* \> 0.05). Subgroup analysis by age and menopausal duration also showed that the decline in renal function was not associated with osteoporosis risk (Additional file [1](#MOESM1){ref-type="media"}: Tables S3 and S4). Table 4Logistic regression of osteoporosisUnadjustedAdjusted^a^*P* valueOR95% CI*P* valueOR95% CIeGFR (ml/min/1.73m^2^)^b^ ≥900.0391.00 (ref)0.7381.00 (ref) \< 901.381.02--1.860.940.67--1.33*CI* confidence interval, *eGFR* estimated glomerular filtration rate, *OR* odds ratio^a^Adjustment for age, menopausal duration and BMI^b^eGFR calculated using the CKD Epidemiology Collaboration 2009 equation

Discussion {#Sec7}
==========

Several studies have concerned to evaluate the association between renal function and BMD \[[@CR5]--[@CR9], [@CR13], [@CR14]\]. However, the literatures are conflicting, and the relationship between renal function and the risk of osteoporosis in healthy older population is rare. In the current study, we examined the relationship of renal function with BMD and the risk of osteoporosis in 776 relatively healthy postmenopausal Chinese women. Our present study found that participants with worse renal function were associated with lower femoral neck and total hip BMD. However, after adjusting for age, menopausal duration and BMI, the decline in renal function was not associated with increased risk of osteoporosis as compared with normal renal function.

As for the relationship between renal function and BMD in the general population, the results are controversial. Kaji et al. \[[@CR7]\] reported a positive relationship between eGFR, calculated using the Modification of Diet in Renal Disease (MDRD) equation for assessing renal function, and BMD in postmenopausal women. Similarly, a retrospective study of 1172 CKD outpatients also described an association between reduced BMD and impaired renal function (using the CKD-EPI equation) \[[@CR5]\]. Ensrud et al. \[[@CR26]\] suggested that lower eGFR, calculated using CKD-EPI 2012 equation, was associated with increased risk of hip fracture in older community-dwelling men. However, Hsu et al. \[[@CR27]\] demonstrated that a decline in renal function was not associated with decreased BMD. Malmgren et al. \[[@CR28]\] also showed that the prevalence of osteoporosis did not differ with renal function. In our study, although Spearman's correlation analysis showed a positive relationship between eGFR and BMD values, this relationship was attenuated after adjustment for potential confounders. We suggest that the discrepancies might be caused by differences in different research population studied, the equations used, skeletal sites observed, and the higher rate of normal population in subjects of the present study. With MDRD equations, the eGFR tends to be underestimated in people with normal renal function \[[@CR29]\]. CKD-EPI equations are shown to be more accurate than MDRD equations to assess renal function in older population and healthy individuals \[[@CR30], [@CR31]\].

In a study of 1,815,943 participants, the association was negative for eGFR and rates of fracture, but after adjusting for additional demographic variables and comorbidities, the relationship disappeared \[[@CR13]\]. Similar to their findings, our study showed that decreased eGFR was associated with reduced BMD; however, after adjustment for age, menopausal duration and BMI, we found no evidence to support the hypothesis that the decline in renal function is independently associated with osteoporosis risk. Why was reduced eGFR not associated with increased osteoporosis risk, in contrast to the excess osteoporosis risk observed in patients with end-stage renal disease (ESRD) \[[@CR32]\]? In comparison to earlier study, we focused on relatively healthy postmenopausal Chinese women, so we excluded subjects with impaired renal function (eGFR \< 60 ml/min/1.73m^2^). This may explain in part why our results differ from previous studies \[[@CR5]\], which included 415 CKD outpatients with eGFR \< 60 ml/min/1.73^2^. In addition, we found that eGFR was associated with age and menopausal duration, both of which are known risk factors for osteoporosis \[[@CR33], [@CR34]\]. Thus, we assume that the association between eGFR and BMD can be explained by known confounding factors, such as age and menopausal duration.

Spearman's correlation analysis of the data showed that SCr was not associated with BMD values. Since SCr levels are affected by muscle mass, it is not accurate for assessing renal function \[[@CR35], [@CR36]\]. Similar to our findings, Han et al. \[[@CR8]\] did not find association between SCr and BMD.

Our study indicates that there are skeletal-site-specific differences in the relationships between BMD levels and eGFR. However, after stratification by age, eGFR did not correlate with BMD at all sites. Those with eGFR \< 90 ml/min/1.73m^2^ were older compared with those with eGFR ≥90 ml/min/1.73m^2^. These findings indicate that the association of lower BMD with lower eGFR was due in large part to age. Several reasons could partly explain the skeletal site-specificity differences. First, the overlying aortic calcifications make it difficult to measure BMD at lumbar spine in the elderly \[[@CR37]\]. Besides, present BMD does not reflect present bone metabolism alone, but rather integrates bone metabolism from the past to present. Finally, spine BMD remains approximately stable or increases over time, whereas BMD of the total hip and femoral neck declines at an increasing rate in elderly people \[[@CR38], [@CR39]\]. In the present study, we focus on relatively healthy subjects with eGFR ≥60 ml/min/1.73m^2^. Thus, further studies are needed to explore the relationship between reduced renal function and BMD in CKD.

The present study has notable strengths including its relatively large sample size, focus on the healthy postmenopausal Chinese women, where data on this population are rare. No participant had taken a drug known to affect bone metabolism and renal function. Besides, important confounding factors were adjusted in the regression analysis. The present study has several potential limitations. Firstly, due to the observational study design, it is impossible to establish a causal relation between renal function and BMD. A longitudinal follow-up study is necessary to ascertain these relationships. Another limitation, which should be mentioned, is that we excluded subjects with impaired renal function (eGFR \< 60 ml/min/1.73m^2^). Thus, our findings might not be applicable to the entire population of Chinese postmenopausal women. In addition, this study included subjects with CKD stage 2 (defined an eGFR 60--90 ml/min/1.73m^2^) \[[@CR23]\]. Thirdly, the great majority of studies concluded that formulas based on serum cystatin C are superior to SCr-based eGFR \[[@CR26], [@CR40]\]. However, Keddis et al. \[[@CR41]\] showed that SCr-based CKD-EPI equation was preferred over cystatin C-based eGFR in kidney transplant recipients because they are less biased, more accurate. Moreover, the gold standard for detecting eGFR is inulin clearance, which is rarely done due to issues with inconvenience and time consuming for epidemiologic studies. Finally, urine protein or imaging examination, for example, is lacking for confirming impaired renal function.

Conclusions {#Sec8}
===========

In conclusion, our data showed that although participants with declined eGFR have significantly reduced femoral neck and total hip BMD, this association disappeared after adjusting for age, menopausal duration and BMI. Renal function itself is not independently associated with the risk of osteoporosis in relatively healthy postmenopausal Chinese women.
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